undamentalytics Newsletter
Sign in

Mangoceuticals, Inc. balance sheet

At the end of fiscal 2025, Mangoceuticals, Inc. had total assets of $16.1m, total liabilities of $890,568 and shareholders' equity of $15.2m. It held $1.5m in cash against $0 of debt: net cash of $1.5m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents11010
Inventory—0———
Total current assets11020
Total assets11151614
Total current liabilities00111
Total debt00000
Total liabilities00112
Shareholders' equity11141513
Net debt (negative = net cash)−1−10−1−0
Shares outstanding—6m10m—18m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ATPC vs MGRXAHG vs MGRXAMS vs MGRX

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Mangoceuticals, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Mangoceuticals, Inc.